Henrik Stenqvist
Directeur Financier/CFO chez SWEDISH ORPHAN BIOVITRUM AB
Fortune : 2 M $ au 30/04/2024
Provenance du réseau au premier degré de Henrik Stenqvist
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 39 | |
25
| Public Company | Pharmaceuticals: Major | 25 |
| Public Company | Pharmaceuticals: Major | 23 | |
| Subsidiary | Pharmaceuticals: Major | 18 | |
12
| Public Company | Pharmaceuticals: Other | 12 |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Swedish Orphan Biovitrum Ltd.
 Swedish Orphan Biovitrum Ltd. Pharmaceuticals: MajorHealth Technology Part of Swedish Orphan Biovitrum AB, Swedish Orphan Biovitrum Ltd. manufactures and sells drugs for rare diseases. The company is based in Cambridge, UK and was founded in 2002.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Henrik Stenqvist via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Lund | College/University | Masters Business Admin Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin Director/Board Member Graduate Degree Graduate Degree | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Public Communications Contact Chief Executive Officer Director/Board Member | |
| University of Uppsala | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Operating Officer | |
| University of Stockholm | College/University | Doctorate Degree Undergraduate Degree Masters Business Admin | |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal General Counsel | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President Corporate Officer/Principal | |
| LIQUIDIA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member General Counsel | |
| MEDA AB | Pharmaceuticals: Major | Investor Relations Contact Director/Board Member Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Investor Relations Contact Corporate Officer/Principal | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| VERONA PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer General Counsel | |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Chief Executive Officer Chief Executive Officer General Counsel | |
| University of Helsinki | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| University of Oslo | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| CANDEL THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| INVESTOR AB | Financial Conglomerates | Director of Finance/CFO Corporate Officer/Principal | |
Elinkeinoelämän Keskusliitto ry
 Elinkeinoelämän Keskusliitto ry Miscellaneous Commercial ServicesCommercial Services Elinkeinoelämän Keskusliitto ry is a business organization based in Helsinki, Finland. and has subsidiaries in Finland. The Finnish company operates as a business organization. The CEO of the private company is Jyri Jukka Häkämies. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Orion Pharma (UK) Ltd.
 Orion Pharma (UK) Ltd. Medical DistributorsDistribution Services Part of Orion Oyj, Orion Pharma (UK) Ltd. is a British company that wholesales and distributes pharmaceutical products. The company is based in Newbury, UK. Orion Pharma (UK was founded in 1996. | Medical Distributors | Director/Board Member Director/Board Member | |
| HKFOODS OYJ | Food: Specialty/Candy | Chief Executive Officer Corporate Officer/Principal | |
Evecxia, Inc.
 Evecxia, Inc. Miscellaneous Commercial ServicesCommercial Services Evecxia, Inc. is engaged in biotechnology services. The company was founded by Jacob Jacobsen and Marc Caron and is headquartered in Research Triangle Park, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
PBM Products LLC
 PBM Products LLC Food: Meat/Fish/DairyConsumer Non-Durables PBM Products LLC entered into an exclusive supply arrangement to introduce the first private-label (store-brand) infant formulas in the United States. Today store-brand infant formulas have become increasingly important to retailers, and an affiliate company, PBM Nutritionals LLC manufactures state-of-the-art formulas for PBM Products and its retail partners. Whether a store brand carries its own retail name or is part of a wholesaler's private-label program, store-brand products give retailers a way to make a higher margin, differentiate themselves from the competition, and win the loyalty of customers. It believes their extensive private-label product lines are helping some of the largest retailers in America accomplish their business goals. In turn, their retail partners are helping them to accomplish its mission. PBM partners with leading food and drug retailers to provide high-quality, competitively priced products to customers labeled under the store brands of companies such as Wal-Mart, Target, Kroger, Loblaws, and Walgreens. | Food: Meat/Fish/Dairy | Chief Executive Officer Corporate Officer/Principal | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| NOKIA OYJ | Telecommunications Equipment | Human Resources Officer Corporate Officer/Principal | |
ORION Pharma GmbH
 ORION Pharma GmbH Pharmaceuticals: MajorHealth Technology Part of Orion Oyj, ORION Pharma GmbH is a German company that develops, manufactures, and markets human and veterinary medicines. The company is based in Hamburg, Germany. The CEOs are Robert Borgdorf, Satu Maarit Ahomäki, Jari Ilmari Karlson. The company was founded in 1991. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| ELISA OYJ | Wireless Telecommunications | Chief Executive Officer Director/Board Member | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
PBM Pharmaceuticals, Inc.
 PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PBM Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Charlottesville, VA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of South Carolina | College/University | Graduate Degree Masters Business Admin | |
| Aalto University School of Science & Technology | College/University | Graduate Degree Graduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
Tolerion, Inc.
 Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Biotechnology | Chairman Director/Board Member | |
| Georgia State University | College/University | Graduate Degree Masters Business Admin | |
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 17 |
| Suède | 14 |
| Finlande | 7 |
| Royaume-Uni | 5 |
| Danemark | 4 |
Sectorielle
| Health Technology | 21 |
| Consumer Services | 16 |
| Commercial Services | 7 |
| Finance | 5 |
| Consumer Non-Durables | 3 |
Opérationnelle
| Director/Board Member | 371 |
| Corporate Officer/Principal | 158 |
| Independent Dir/Board Member | 114 |
| Chairman | 108 |
| Chief Executive Officer | 71 |
Relations les plus connectées
| Insiders | |
|---|---|
| Sven Håkan Björklund | 46 |
| Bo Jesper Hansen | 34 |
| Elmar Schnee | 31 |
| Sean Stalfort | 28 |
| Paul Manning | 26 |
| Renée Aguiar-Lucander | 26 |
| Ari Tapio Lehtoranta | 23 |
| Johannes G. C. P. Schikan | 22 |
| Ola Harald Erici | 22 |
| Veli-Matti Johannes Mattila | 22 |
| Hilde Furberg | 21 |
| Fred Driscoll | 21 |
| Nancy Wysenski | 20 |
| Sven Anders Ullman | 19 |
| Anders Egon Svensson | 19 |
- Bourse
- Insiders
- Henrik Stenqvist
- Connexions Sociétés
